Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-11-07
1998-02-17
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540547, C07D26720, C07D28116, A61K 3155
Patent
active
057191409
ABSTRACT:
The present invention provides substituted dibenzoxazepine compounds of Formula I: ##STR1## which are useful as analgesic agents for the treatment of pain, and as prostaglandin-E.sub.2 antagonists for the treatment of prostaglandin-E.sub.2 mediated diseases, pharmaceutical compositions comprising a therapeutically-effective amount of a compound of Formula I in combination with a pharmaceutically-acceptable carrier, a method for eliminating or ameliorating pain in an animal, and a method for treating prostaglandin-E.sub.2 mediated diseases in an animal, comprising administering a therapeutically-effective amount of a compound of Formula I to the animal.
REFERENCES:
patent: 2852528 (1958-09-01), Hoffmann et al.
patent: 3210372 (1965-10-01), Werner et al.
patent: 3357998 (1967-12-01), Cusic et al.
patent: 3534019 (1970-10-01), Coyne et al.
patent: 3624104 (1971-11-01), Cusic et al.
patent: 3917649 (1975-11-01), Mueller
patent: 3989719 (1976-11-01), Mueller
patent: 3992375 (1976-11-01), Mueller
patent: 4045442 (1977-08-01), Mueller
patent: 4125532 (1978-11-01), Mueller
patent: 4170593 (1979-10-01), Mueller
patent: 4290953 (1981-09-01), Koizumi et al.
patent: 4379150 (1983-04-01), Ito et al.
patent: 4559336 (1985-12-01), Mueller
patent: 4559337 (1985-12-01), Mueller
patent: 4614617 (1986-09-01), Mueller
patent: 4681939 (1987-07-01), Mueller
patent: 4704386 (1987-11-01), Mueller
patent: 5180720 (1993-01-01), Husa et al.
patent: 5182272 (1993-01-01), Hellinan et al.
patent: 5212169 (1993-05-01), Husa et al.
patent: 5225417 (1993-07-01), Dappen et al.
patent: 5281590 (1994-01-01), Husa et al.
patent: 5283240 (1994-02-01), Hallinan et al.
patent: 5288719 (1994-02-01), Husa et al.
patent: 5304644 (1994-04-01), Husa et al.
patent: 5317101 (1994-05-01), Oldfield et al.
patent: 5354863 (1994-10-01), Dappen et al.
patent: 5395932 (1995-03-01), Chandrakumar
V.P. Arya et al. "Antihypertensive Agents: Part IV*-Synthesis & Hypotensive Activity of Certain 2-Substituted 4,5-Dihydromidazoles," Indian Journal of Chemistry, 15B, 148-153 Feb. (1977) -- India.
A. Bennett, et al. "Antagonism of Prostanoid-Induced Contractions of Rat Gastric Fundus Muscle by SC-19220 Sodium Meclofenamate, Indomethacin or Trimethoquinol," Br. J. Pharmac., 71, 169-175 (1980) -- London.
W.E. Coyne, et al. "Anticonvulsant Semicarbazides," J. Med. Chem., 11(6), 1158-1160 (1988) -- USA.
E.J. Drower, et al. "The Antiociceptive Effects of Prostaglandin Antagonists in the Rat," European Journal of Phrarmacology, 133, 249-256 (1987) -- Europe.
F.R. George, et al. "Antagonism of Alcohol Hypnosis by Blockade of Prostaglandin Synthesis and Activity: Genotype and Time Course Effects," Pharmacology, Biochemistry & Behavior, vol. 19, 131-136 (1983) -- USA.
R. Gimet, et al. "Quantitative Determination of Polymorphic Forms in a Formulation Matrix Using the Near Infra-Red Reflectance Analysis Technique," Journal of Pharmaceutical & Biomedical Analysis, vol. 5, No. 3, 205-211 (1987) -- Great Britain.
A. Gomes, et al. "Pharmacodynamics of Venom of the Centipede Scolopendra Subspinipes Dehaeni," Indian Journal of Experimental Biology, vol. 20, 615-618, Aug. (1982) -- India.
K. Gyires, et al. "The Use of the Writhing Test in Mice for Screening Different Types of Analgesics," Arch. Int. Pharmacodyn, 267, 131-140 (1984) -- USA.
D.E. MacIntyre, et al. "Antagonism of Human Platelet Responses to Stimulatory and Inhibitory Prostaglandins," Prog. Lipid. Res., 20 (1-4), 453-9 (1981) -- USA.
C.A. Maggi, et al. "The Effect of SC-19220, a Prostaglandin Antagonist, on the Micturition Reflex in Rats," European Journal of Pharmacology, 152, 273-279 (1988) -- Europe. Derivative as Potential Anticonvulsant & Psychotropic Agents," Indian Journal of Chemistry, vol. 248, 840-844 (1985) -- India.
S. Nakajyo, et al. "Inhibitory Effect of Bassianolide, a Cyclodepsipeptide, on Drug-Induced Contractions of Isolated Smooth Muscle Preparations," Japan J. Pharmacol., 32, 55-64 (1982) -- Japan.
A. Rakovska, et al. "Antagonistic Effect of SC-19220 on the Responses of Guinea-Pig Gastric Muscles to Prostaglandins E.sub.1, E.sub.2, and F.sub.2.alpha.," Arch. Int. Pharmacodyn., 268, 59-69 (1984) -- USA.
J.H. Sanner "Dibenzoxazepine Hydrazides as Prostaglandin Antagonists," Intra-Science Chem. Rept., vol. 6, No. 1, 1-9 (1972) -- USA.
J.H. Sanner, et al. "Structure-Activity Relationships of Some Dibenzoxazepine Derivatives as Prostaglandin Antagonists," Advances in the Biosciences, 9, 139-148 (1972) -- USA.
L.H.Werner, et al. "Imidazoline Derivatives with Antiarryhthmic Activity," Journal of Med. Chem., vol. 10(4), 575-582, Jul., (1967) -- USA.
L.H.Werner, et al. "38-Heterocyclic Compounds: Thiazepine Derivatives," Chemical Abstracts, 8325-8326 (1964) -- USA.
07/813,316 Dec. 20, 1991 T. Hagen, et al. (2690).
Chandrakumar Nizal Samuel
Hagen Timothy Joseph
Hallinan E. Ann
Pitzele Barnett Sylvain
Tsymbalov Sofya
Ford John M.
G.D. Searle & Co.
LandOfFree
2, 3-, 4-, 5-, 6-, 7-, 8-, 9- and /or 10-substituted dibenzoxaze does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2, 3-, 4-, 5-, 6-, 7-, 8-, 9- and /or 10-substituted dibenzoxaze, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2, 3-, 4-, 5-, 6-, 7-, 8-, 9- and /or 10-substituted dibenzoxaze will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1784112